{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T05:26:55Z","timestamp":1738906015131,"version":"3.37.0"},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,12,30]],"date-time":"2008-12-30T00:00:00Z","timestamp":1230595200000},"content-version":"vor","delay-in-days":8764,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Anaesthesiol Scand"],"published-print":{"date-parts":[[1985,1]]},"abstract":"<jats:p>The effects of continuously administered intravenous propoxyphene chloride (15 mg\u22c5min<jats:sup>\u20101<\/jats:sup>) on ECG, systemic, pulmonary and coronary circulations and myocardial oxygenation were investigated in eight pentobarbital\u2010anesthetized pigs. Circulatory shock, defined as a systolic blood pressure below 60 mmHg (8.0 kPa) and a cardiac output of approximately 2.0 1 \u22c5 min<jats:sup>\u20101<\/jats:sup>\u22c5 m<jats:sup>\u20102<\/jats:sup>, occurred after 675 to 2025 mg propoxyphene chloride. At the time when shock occurred plasma concentrations of propoxyphene ranged from 9.6 to 15.3 \u03bcg\u2010ml<jats:sup>\u20101<\/jats:sup>which is within the range of the lethal concentration observed in man. Statistically significant decreases were observed for the following variables: maximum rate of rise of left ventricular pressure dP\/dt (\u201390%), mean arterial pressure (\u2013 73%), heart rate (\u2013 46%), cardiac index (\u2013 58%), stroke volume index (\u201322%), left ventricular stroke work index (\u201385%), right ventricular stroke work index (\u201363%) and systemic vascular resistance (\u2013 50%). Mean pulmonary arteriolar occlusion pressure increased (+ 42%), whereas mean right atrial pressure and pulmonary vascular resistance remained unchanged. The arteriovenous oxygen difference increased (+ 53%) and total body oxygen consumption decreased (\u201335%). The following coronary variables decreased: coronary sinus blood flow (\u2013 57%), coronary vascular resistance (\u2013 65%), myocardial oxygen consumption (\u2013 68%), myocardial oxygen extraction (\u2013 26%) and myocardial lactate extraction (\u2013 28%). Prolongation of the ECG PQ and QRS intervals were recorded shortly before shock appeared, and all animals were in sinus rhythm till the last minute before death. The results indicate that intravenously administered propoxyphene besides being a powerful negative inotropic and chronotropic agent, is also a potent systemic and coronary vasodilator.<\/jats:p>","DOI":"10.1111\/j.1399-6576.1985.tb02173.x","type":"journal-article","created":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T11:09:05Z","timestamp":1230808145000},"page":"130-136","source":"Crossref","is-referenced-by-count":13,"title":["Circulatory Shock Following Intravenous Propoxyphene Poisoning. An Experimental Study of Cardiac Function and Metabolism in Pentobarbital\u2010Anesthetized Pigs"],"prefix":"10.1111","volume":"29","author":[{"given":"M. BREDGAARD","family":"S\u00d8RENSEN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"H\u00c4GGMARK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"NYHMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. SLOTH","family":"MADSEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"STR\u00d8M","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"REIZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,30]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"338","article-title":"Acute poisoning with drugs containing dextropropoxyphenc","volume":"9","author":"Gr\u00f6nvall G","year":"1971","journal-title":"Opusc Med"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1976.tb08226.x"},{"key":"e_1_2_1_4_2","first-page":"1636","article-title":"Twenty\u2010one cases of poisoning with dextropropoxyphene chloride alone or in combination with other drugs","volume":"138","author":"Serafimovski N","year":"1976","journal-title":"Ugeskr Laeg"},{"key":"e_1_2_1_5_2","unstructured":"Sloth MadsenP Str\u00f8mJ ReizS Bredgaard S\u00f8rensenM.Two hundred and twenty two cases of severe dextropropoxyphene poisoning.Acta Anaesthesiol Scand.In press."},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1967.03120130092024"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.129.1.62"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(79)90079-6"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198101000-00011"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.44.2.181"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365517709098933"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/50.5.445"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1979264473"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1978.tb02187.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(79)90405-8"},{"key":"e_1_2_1_16_2","first-page":"575","article-title":"Cardiopulmonary, behavioral and pharmacokinetic effects of propoxyphene in horses","volume":"41","author":"Muir WW","year":"1980","journal-title":"Am JVet Res"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(71)90003-2"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(67)90049-X"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(79)90541-0"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1974153302"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt197517115"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.179.4077.1011"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0022-3565(25)30762-7","article-title":"Propoxyphene and norpropoxyphene: pharmacologic and toxic effects in animals","volume":"200","author":"Nickander R","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1520\/JFS10072J"}],"container-title":["Acta Anaesthesiologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-6576.1985.tb02173.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-6576.1985.tb02173.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T17:45:00Z","timestamp":1738863900000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-6576.1985.tb02173.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1985,1]]}},"alternative-id":["10.1111\/j.1399-6576.1985.tb02173.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-6576.1985.tb02173.x","archive":["Portico"],"relation":{},"ISSN":["0001-5172","1399-6576"],"issn-type":[{"type":"print","value":"0001-5172"},{"type":"electronic","value":"1399-6576"}],"subject":[],"published":{"date-parts":[[1985,1]]}}}